tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Cellectis SA (CMVLF)
OTHER OTC:CMVLF
US Market
CMVLF
Cellectis SA
Overview
Analyst Forecasts
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Cellectis SA (CMVLF) Stock News & Sentiment

Compare
8 Followers
Cellectis SA’s Promising Study on UCART20x22 for B-Cell Non-Hodgkin Lymphoma
Premium
Company Announcements
Cellectis SA’s Promising Study on UCART20x22 for B-Cell Non-Hodgkin Lymphoma
3d ago
CMVLF
Cellectis SA: Hold Rating Amid Upcoming Data Presentations and Financial Considerations
Premium
Ratings
Cellectis SA: Hold Rating Amid Upcoming Data Presentations and Financial Considerations
1M ago
CLLS
Cellectis S.A. Advances UCART123 Clinical Study in AML Treatment
Premium
Company Announcements
Cellectis S.A. Advances UCART123 Clinical Study in AML Treatment
1M ago
CLLS
Cellectis Reports Q2 2025 Results and Strategic Updates
Premium
Company Announcements
Cellectis Reports Q2 2025 Results and Strategic Updates
1M ago
CMVLF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CMVLF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Cautious Hold on Cellectis SA Amid Anticipated Data Releases and Strategic Developments
Premium
Ratings
Cautious Hold on Cellectis SA Amid Anticipated Data Releases and Strategic Developments
4M ago
CLLS
Cellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
Premium
Ratings
Cellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
4M ago
CLLS
More CMVLF News >

CMVLF News on the Web

Cellectis Second Quarter 2025 Earnings: US$0.24 loss per share (vs US$0.28 loss in 2Q 2024)
Simply Wall St
Neutral
Cellectis S.A. (EPA:ALCLS) Stock Catapults 30% Though Its Price And Business Still Lag The Industry
Simply Wall St
Neutral
It's Unlikely That Cellectis S.A.'s (EPA:ALCLS) CEO Will See A Huge Pay Rise This Year
Simply Wall St
Neutral
European Penny Stocks To Consider In May 2025
Simply Wall St
Neutral
Need To Know: The Consensus Just Cut Its Cellectis S.A. (EPA:ALCLS) Estimates For 2025
Simply Wall St
Neutral
Cellectis First Quarter 2025 Earnings: US$0.18 loss per share (vs US$0.079 profit in 1Q 2024)
Simply Wall St
Neutral
Improved Revenues Required Before Cellectis S.A. (EPA:ALCLS) Stock's 32% Jump Looks Justified
Simply Wall St
Neutral
Discover European Penny Stocks: I.M.D. International Medical Devices And 2 More To Watch
Simply Wall St
Neutral

News Score - Last 7 Days

Neutral
CMVLF
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CMVLF’s Media Buzz Sentiment?
Currently, no data Available
What is CMVLF’s weekly average amount of articles?
Currently, no data Available
What is CMVLF’s News Sentiment?
59% of articles about CMVLF were positive this week, compared to its sector average of 56%.
    Healthcare Stocks that are Trending in the News
    HALOHalozyme
    PHRPhreesia
    AGIOAgios Pharma
    IMVTImmunovant
    STTKShattuck Labs
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing